Gambogic acid suppresses the pentose phosphate pathway by covalently inhibiting 6PGD protein in cancer cells

Here, we report for the first time the anticancer mechanism of gambogic acid, which covalently inhibits the key rate-limiting enzyme 6PGD in the pentose phosphate pathway, thereby effectively suppressing the metabolic process of cancer cells.